These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28114114)

  • 1. Scenario-based radiation therapy margins for patient setup, organ motion, and particle range uncertainty.
    Bokrantz R; Fredriksson A
    Phys Med Biol; 2017 Feb; 62(4):1342-1357. PubMed ID: 28114114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.
    Liu W; Liao Z; Schild SE; Liu Z; Li H; Li Y; Park PC; Li X; Stoker J; Shen J; Keole S; Anand A; Fatyga M; Dong L; Sahoo N; Vora S; Wong W; Zhu XR; Bues M; Mohan R
    Pract Radiat Oncol; 2015; 5(2):e77-86. PubMed ID: 25413400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The scenario-based generalization of radiation therapy margins.
    Fredriksson A; Bokrantz R
    Phys Med Biol; 2016 Mar; 61(5):2067-82. PubMed ID: 26895381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
    Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical robustness evaluation in radiotherapy - A photon and proton-proof alternative to PTV-based plan evaluation.
    Korevaar EW; Habraken SJM; Scandurra D; Kierkels RGJ; Unipan M; Eenink MGC; Steenbakkers RJHM; Peeters SG; Zindler JD; Hoogeman M; Langendijk JA
    Radiother Oncol; 2019 Dec; 141():267-274. PubMed ID: 31492443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton therapy of prostate cancer by anterior-oblique beams: implications of setup and anatomy variations.
    Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
    Phys Med Biol; 2017 Mar; 62(5):1644-1660. PubMed ID: 28166057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical evaluation of worst case optimization methods for robust intensity-modulated proton therapy planning.
    Fredriksson A; Bokrantz R
    Med Phys; 2014 Aug; 41(8):081701. PubMed ID: 25086511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust radiotherapy planning.
    Unkelbach J; Alber M; Bangert M; Bokrantz R; Chan TCY; Deasy JO; Fredriksson A; Gorissen BL; van Herk M; Liu W; Mahmoudzadeh H; Nohadani O; Siebers JV; Witte M; Xu H
    Phys Med Biol; 2018 Nov; 63(22):22TR02. PubMed ID: 30418942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
    Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
    J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel and individualized robust optimization method using normalized dose interval volume constraints (NDIVC) for intensity-modulated proton radiotherapy.
    Shan J; Sio TT; Liu C; Schild SE; Bues M; Liu W
    Med Phys; 2019 Jan; 46(1):382-393. PubMed ID: 30387870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
    Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
    Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical assessment of proton treatment plans under setup and range uncertainties.
    Park PC; Cheung JP; Zhu XR; Lee AK; Sahoo N; Tucker SL; Liu W; Li H; Mohan R; Court LE; Dong L
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):1007-13. PubMed ID: 23688812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards fast and robust 4D optimization for moving tumors with scanned proton therapy.
    Buti G; Souris K; Montero AMB; Lee JA; Sterpin E
    Med Phys; 2019 Dec; 46(12):5434-5443. PubMed ID: 31595521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortening delivery times of intensity modulated proton therapy by reducing proton energy layers during treatment plan optimization.
    van de Water S; Kooy HM; Heijmen BJ; Hoogeman MS
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):460-8. PubMed ID: 25823447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
    Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
    Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.
    Li H; Zhang X; Park P; Liu W; Chang J; Liao Z; Frank S; Li Y; Poenisch F; Mohan R; Gillin M; Zhu R
    Radiother Oncol; 2015 Mar; 114(3):367-72. PubMed ID: 25708992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of internal organ motion-induced variance in radiation dose in non-gated radiotherapy.
    Zhou S; Zhu X; Zhang M; Zheng D; Lei Y; Li S; Bennion N; Verma V; Zhen W; Enke C
    Phys Med Biol; 2016 Dec; 61(23):8157-8179. PubMed ID: 27804926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robustness Recipes for Minimax Robust Optimization in Intensity Modulated Proton Therapy for Oropharyngeal Cancer Patients.
    van der Voort S; van de Water S; Perkó Z; Heijmen B; Lathouwers D; Hoogeman M
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):163-170. PubMed ID: 27084639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating the effect of fractionation in the evaluation of proton plan robustness to setup errors.
    Lowe M; Albertini F; Aitkenhead A; Lomax AJ; MacKay RI
    Phys Med Biol; 2016 Jan; 61(1):413-29. PubMed ID: 26675133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.